 Bahram Salmanian
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta Accreta | 18 | 2023 | 27 | 6.780 |
Why?
| | Placenta Previa | 7 | 2022 | 9 | 2.150 |
Why?
| | Cesarean Section | 16 | 2023 | 184 | 1.960 |
Why?
| | Hysterectomy | 11 | 2022 | 129 | 1.360 |
Why?
| | Pregnancy | 42 | 2025 | 6763 | 1.230 |
Why?
| | Pre-Eclampsia | 4 | 2025 | 190 | 1.200 |
Why?
| | Ultrasonography, Prenatal | 7 | 2025 | 285 | 1.130 |
Why?
| | Umbilical Arteries | 2 | 2025 | 55 | 1.100 |
Why?
| | Fertilization in Vitro | 3 | 2021 | 83 | 0.980 |
Why?
| | Umbilical Veins | 1 | 2025 | 62 | 0.950 |
Why?
| | Ultrasonography, Doppler | 1 | 2025 | 124 | 0.910 |
Why?
| | Infant, Small for Gestational Age | 1 | 2025 | 92 | 0.900 |
Why?
| | Albuminuria | 1 | 2025 | 185 | 0.860 |
Why?
| | Fetal Growth Retardation | 2 | 2025 | 565 | 0.710 |
Why?
| | Fetal Diseases | 4 | 2015 | 173 | 0.690 |
Why?
| | Blood Transfusion | 3 | 2023 | 325 | 0.660 |
Why?
| | Placenta | 9 | 2023 | 750 | 0.580 |
Why?
| | Female | 45 | 2025 | 73304 | 0.450 |
Why?
| | Hydrothorax | 1 | 2014 | 3 | 0.440 |
Why?
| | Cardiac Tamponade | 1 | 2014 | 12 | 0.430 |
Why?
| | Fetofetal Transfusion | 3 | 2022 | 26 | 0.420 |
Why?
| | Retrospective Studies | 22 | 2023 | 15657 | 0.410 |
Why?
| | Postpartum Hemorrhage | 3 | 2023 | 17 | 0.400 |
Why?
| | Blood Component Transfusion | 3 | 2021 | 84 | 0.380 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2014 | 201 | 0.350 |
Why?
| | Humans | 45 | 2025 | 137585 | 0.320 |
Why?
| | Cohort Studies | 8 | 2025 | 5742 | 0.300 |
Why?
| | Iran | 3 | 2025 | 43 | 0.300 |
Why?
| | Pregnancy Outcome | 8 | 2022 | 416 | 0.290 |
Why?
| | Infant, Newborn | 10 | 2025 | 6079 | 0.260 |
Why?
| | Adult | 24 | 2025 | 37929 | 0.240 |
Why?
| | Blood Loss, Surgical | 4 | 2019 | 101 | 0.240 |
Why?
| | Astigmatism | 2 | 2016 | 10 | 0.240 |
Why?
| | Sterilization, Tubal | 2 | 2015 | 16 | 0.240 |
Why?
| | Photorefractive Keratectomy | 2 | 2016 | 19 | 0.240 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2023 | 394 | 0.240 |
Why?
| | Myopia | 2 | 2016 | 47 | 0.230 |
Why?
| | Social Justice | 2 | 2015 | 73 | 0.230 |
Why?
| | Nuchal Translucency Measurement | 2 | 2013 | 3 | 0.210 |
Why?
| | Laser Therapy | 2 | 2015 | 130 | 0.210 |
Why?
| | Creatinine | 1 | 2025 | 499 | 0.200 |
Why?
| | Delivery, Obstetric | 2 | 2016 | 144 | 0.200 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2023 | 69 | 0.190 |
Why?
| | Chorioamnionitis | 1 | 2022 | 42 | 0.190 |
Why?
| | Prenatal Diagnosis | 2 | 2021 | 201 | 0.190 |
Why?
| | Betamethasone | 2 | 2012 | 20 | 0.190 |
Why?
| | Erythrocyte Transfusion | 3 | 2019 | 194 | 0.190 |
Why?
| | Incidence | 3 | 2025 | 2804 | 0.190 |
Why?
| | Obstetric Labor, Premature | 2 | 2012 | 36 | 0.190 |
Why?
| | Obstetric Labor Complications | 1 | 2022 | 34 | 0.190 |
Why?
| | Apgar Score | 1 | 2021 | 17 | 0.180 |
Why?
| | Heart Rate, Fetal | 1 | 2021 | 21 | 0.180 |
Why?
| | Obstetrics | 1 | 2023 | 163 | 0.180 |
Why?
| | Urologic Diseases | 1 | 2021 | 41 | 0.180 |
Why?
| | Embryo Transfer | 1 | 2021 | 32 | 0.180 |
Why?
| | Gestational Age | 7 | 2022 | 910 | 0.180 |
Why?
| | Labor, Obstetric | 1 | 2021 | 61 | 0.180 |
Why?
| | Anemia | 1 | 2022 | 170 | 0.170 |
Why?
| | Intraoperative Complications | 1 | 2021 | 138 | 0.170 |
Why?
| | Premature Birth | 2 | 2022 | 333 | 0.160 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2031 | 0.160 |
Why?
| | Hypocalcemia | 1 | 2019 | 27 | 0.150 |
Why?
| | Social Determinants of Health | 1 | 2023 | 267 | 0.150 |
Why?
| | Placenta, Retained | 2 | 2017 | 2 | 0.150 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 91 | 0.150 |
Why?
| | Patient Care Team | 3 | 2019 | 631 | 0.150 |
Why?
| | Fetoscopy | 2 | 2015 | 30 | 0.150 |
Why?
| | Placenta Diseases | 1 | 2018 | 18 | 0.140 |
Why?
| | Risk Factors | 7 | 2023 | 10388 | 0.140 |
Why?
| | Heart Defects, Congenital | 2 | 2017 | 842 | 0.140 |
Why?
| | Lasers, Excimer | 2 | 2016 | 28 | 0.140 |
Why?
| | Severity of Illness Index | 2 | 2023 | 2828 | 0.140 |
Why?
| | Hydrops Fetalis | 1 | 2017 | 13 | 0.140 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2017 | 37 | 0.140 |
Why?
| | Odds Ratio | 1 | 2020 | 1070 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2020 | 512 | 0.130 |
Why?
| | Infertility, Female | 1 | 2017 | 108 | 0.130 |
Why?
| | Hemorrhage | 1 | 2021 | 722 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1509 | 0.130 |
Why?
| | Prospective Studies | 3 | 2025 | 7604 | 0.120 |
Why?
| | Vasa Previa | 1 | 2015 | 2 | 0.120 |
Why?
| | Interdisciplinary Communication | 1 | 2017 | 191 | 0.120 |
Why?
| | Lymphatic Abnormalities | 1 | 2015 | 19 | 0.120 |
Why?
| | Renal Veins | 1 | 2015 | 19 | 0.120 |
Why?
| | Whooping Cough | 1 | 2015 | 51 | 0.120 |
Why?
| | Young Adult | 8 | 2023 | 13209 | 0.120 |
Why?
| | Tachycardia, Supraventricular | 1 | 2015 | 43 | 0.120 |
Why?
| | Birth Weight | 4 | 2022 | 516 | 0.110 |
Why?
| | Treatment Outcome | 7 | 2018 | 10811 | 0.110 |
Why?
| | Corneal Pachymetry | 1 | 2014 | 15 | 0.110 |
Why?
| | Hernia, Diaphragmatic | 1 | 2014 | 65 | 0.110 |
Why?
| | Biomarkers | 1 | 2025 | 4149 | 0.100 |
Why?
| | Fetal Therapies | 1 | 2014 | 42 | 0.100 |
Why?
| | Cornea | 1 | 2014 | 138 | 0.100 |
Why?
| | Thyroxine | 1 | 2013 | 62 | 0.100 |
Why?
| | Clinical Protocols | 1 | 2014 | 271 | 0.100 |
Why?
| | Venous Thrombosis | 1 | 2015 | 190 | 0.100 |
Why?
| | Receptors, Opioid, mu | 1 | 2013 | 74 | 0.100 |
Why?
| | Placental Circulation | 1 | 2013 | 71 | 0.100 |
Why?
| | Cervix Uteri | 1 | 2012 | 48 | 0.100 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 140 | 0.100 |
Why?
| | Morphine | 1 | 2013 | 158 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 496 | 0.090 |
Why?
| | Uterine Cervical Diseases | 1 | 2011 | 6 | 0.090 |
Why?
| | Urinary Incontinence, Stress | 1 | 2010 | 15 | 0.090 |
Why?
| | Liver Diseases | 1 | 2014 | 315 | 0.090 |
Why?
| | Laparoscopy | 1 | 2015 | 466 | 0.080 |
Why?
| | Pregnancy Complications | 2 | 2013 | 527 | 0.080 |
Why?
| | United States | 3 | 2022 | 14841 | 0.080 |
Why?
| | Laser Coagulation | 2 | 2022 | 68 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 494 | 0.080 |
Why?
| | Fullerenes | 1 | 2008 | 17 | 0.070 |
Why?
| | Porphyrins | 1 | 2008 | 23 | 0.070 |
Why?
| | Magnetics | 1 | 2008 | 48 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2023 | 3556 | 0.070 |
Why?
| | Magnesium | 1 | 2008 | 156 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2013 | 915 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 2654 | 0.070 |
Why?
| | Maternal Age | 2 | 2017 | 129 | 0.070 |
Why?
| | Cytokines | 2 | 2012 | 2085 | 0.060 |
Why?
| | Adenosine Triphosphate | 1 | 2008 | 491 | 0.060 |
Why?
| | Pregnancy, Twin | 2 | 2016 | 19 | 0.060 |
Why?
| | Placentation | 2 | 2015 | 45 | 0.050 |
Why?
| | Pregnancy Trimester, Second | 2 | 2014 | 80 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1946 | 0.050 |
Why?
| | Myocardium | 1 | 2008 | 1002 | 0.050 |
Why?
| | Texas | 1 | 2023 | 244 | 0.050 |
Why?
| | Nanoparticles | 1 | 2008 | 481 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4295 | 0.050 |
Why?
| | Cardiotocography | 1 | 2021 | 3 | 0.050 |
Why?
| | Child | 1 | 2022 | 21935 | 0.050 |
Why?
| | Blood Gas Analysis | 1 | 2021 | 74 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2017 | 5472 | 0.040 |
Why?
| | Acidosis | 1 | 2021 | 101 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2837 | 0.040 |
Why?
| | Iron | 1 | 2022 | 313 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2019 | 35 | 0.040 |
Why?
| | Family | 1 | 2023 | 671 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2019 | 67 | 0.040 |
Why?
| | Perinatal Mortality | 1 | 2017 | 16 | 0.030 |
Why?
| | Plasma | 1 | 2019 | 212 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2017 | 38 | 0.030 |
Why?
| | Breech Presentation | 1 | 2016 | 1 | 0.030 |
Why?
| | Emergencies | 1 | 2017 | 164 | 0.030 |
Why?
| | Refraction, Ocular | 1 | 2016 | 37 | 0.030 |
Why?
| | Polyhydramnios | 1 | 2015 | 17 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2016 | 5131 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 108 | 0.030 |
Why?
| | Fetal Death | 1 | 2014 | 55 | 0.030 |
Why?
| | Morbidity | 1 | 2015 | 324 | 0.030 |
Why?
| | Abortion, Eugenic | 1 | 2013 | 3 | 0.030 |
Why?
| | Karyotype | 1 | 2013 | 18 | 0.030 |
Why?
| | Twins, Monozygotic | 1 | 2014 | 203 | 0.030 |
Why?
| | Thyroid Function Tests | 1 | 2013 | 14 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3284 | 0.030 |
Why?
| | Nitrites | 1 | 2013 | 84 | 0.020 |
Why?
| | Thyrotropin | 1 | 2013 | 114 | 0.020 |
Why?
| | Prenatal Care | 1 | 2015 | 294 | 0.020 |
Why?
| | Hypothyroidism | 1 | 2013 | 72 | 0.020 |
Why?
| | Nitrates | 1 | 2013 | 92 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2074 | 0.020 |
Why?
| | Tomography, Optical Coherence | 1 | 2014 | 213 | 0.020 |
Why?
| | Nitric Oxide Synthase | 1 | 2013 | 240 | 0.020 |
Why?
| | Rats | 2 | 2013 | 5647 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2017 | 642 | 0.020 |
Why?
| | Reference Values | 1 | 2013 | 816 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 759 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2013 | 181 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 199 | 0.020 |
Why?
| | Renal Insufficiency | 1 | 2013 | 162 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4030 | 0.020 |
Why?
| | Parity | 1 | 2010 | 126 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 843 | 0.020 |
Why?
| | Fetal Development | 1 | 2013 | 296 | 0.020 |
Why?
| | Middle Aged | 3 | 2017 | 33479 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 513 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 840 | 0.020 |
Why?
| | Interleukins | 1 | 2011 | 250 | 0.020 |
Why?
| | Neutron Diffraction | 1 | 2008 | 3 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1215 | 0.020 |
Why?
| | Scattering, Small Angle | 1 | 2008 | 26 | 0.020 |
Why?
| | Isotopes | 1 | 2008 | 33 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 657 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2008 | 156 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2008 | 126 | 0.020 |
Why?
| | Postpartum Period | 1 | 2010 | 340 | 0.020 |
Why?
| | Drug Discovery | 1 | 2008 | 142 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2486 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2008 | 455 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2008 | 560 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2011 | 1993 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1242 | 0.020 |
Why?
| | Kidney | 1 | 2013 | 1468 | 0.010 |
Why?
| | Heart | 1 | 2008 | 655 | 0.010 |
Why?
| | Time Factors | 1 | 2015 | 6828 | 0.010 |
Why?
| | Oxygen | 1 | 2008 | 931 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3566 | 0.010 |
Why?
| | Adolescent | 2 | 2012 | 21513 | 0.010 |
Why?
| | Mitochondria | 1 | 2008 | 948 | 0.010 |
Why?
| | Hypoxia | 1 | 2008 | 1112 | 0.010 |
Why?
| | Animals | 2 | 2013 | 36940 | 0.010 |
Why?
| | Male | 2 | 2014 | 67762 | 0.010 |
Why?
|
|
Salmanian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|